| 24th Feb 2010 4:26 pm |
BUS |
Pfizer Receives FDA Approval for Prevnar 13™ for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children |
| 23rd Feb 2010 7:00 am |
BUS |
Lilly, Merck, And Pfizer Join Forces To Accelerate Research And Improve Treatment Of Lung And Gastric Cancers In Asia |
| 8th Feb 2010 12:33 pm |
BUS |
Pfizer and Keas Partner to Help Consumers Take a More Active Role in Their Health and Wellness |
| 5th Feb 2010 7:00 am |
BUS |
QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients |
| 3rd Feb 2010 12:00 pm |
BUS |
Pfizer Reports Fourth-Quarter and Full-Year 2009 Results; Provides 2010 Financial Guidance and 2012 Financial Targets |
| 27th Jan 2010 5:00 pm |
BUS |
New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics And High-Priority Disease Areas |
| 22nd Jan 2010 1:00 pm |
BUS |
Data Show Progression-Free Survival Advantage With Sutent® In Patients With Pancreatic Neuroendocrine Tumors |
| 21st Jan 2010 12:00 pm |
BUS |
Pfizer and Auxilium Announce Commencement of European Regulatory Review of XIAFLEXTM for the Treatment of Dupuytren's Contracture |
| 7th Jan 2010 1:01 pm |
BUS |
Pfizer And Debiopharm Collaborate To Co-Develop Investigational Compound Tremelimumab (CP-675,206) In Advanced Melanoma |
| 6th Jan 2010 3:00 pm |
BUS |
Pfizer and Strides Arcolab to Collaborate on Generic Products |
| 4th Jan 2010 5:15 pm |
BUS |
European Commission Approves New Intravenous Formulation Of Pfizer's Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension |
| 31st Dec 2009 7:00 am |
BUS |
Pfizer Provides U.S. Regulatory Update On Prevnar 13™ Vaccine |
| 30th Dec 2009 7:00 am |
BUS |
Pfizer Discontinues A Phase 3 Trial Of Figitumumab In Non-Small Cell Lung Cancer (NSCLC) For Futility |
| 24th Dec 2009 7:00 am |
BUS |
Pfizer's Lyrica Receives Complete Response Letter From FDA For Generalized Anxiety Disorder Monotherapy Treatment |
| 18th Dec 2009 6:16 pm |
BUS |
Despite Stresses of Today, Survey Finds Women and Men Set Health and Wellness Goals - But Sex Often Influences Success |
| 18th Dec 2009 7:00 am |
BUS |
FDA Approves SPIRIVA® HandiHaler® for the Reduction of COPD Exacerbations |
| 17th Dec 2009 7:00 am |
BUS |
Toviaz 8 Mg Was More Effective Than Detrol LA In Treating Urge Urinary Incontinence In Patients With Overactive Bladder |
| 15th Dec 2009 2:32 pm |
BUS |
Takeda and Pfizer to Co-Promote Takeda's Actos® (Pioglitazone HCl) for the Treatment of Type 2 Diabetes in China |
| 15th Dec 2009 7:00 am |
BUS |
Pfizer Declares an 18-Cent First-Quarter 2010 Dividend |
| 14th Dec 2009 7:00 am |
BUS |
Pfizer Announces Neratinib Data In HER2 Positive Breast Cancer |
| 14th Dec 2009 7:00 am |
BUS |
Pfizer Inc. Affirms Confidence In Its Hormone Therapy Medicines As Important Treatment Options |
| 11th Dec 2009 10:52 am |
BUS |
Pfizer Receives European Authorization For Prevenar 13* For The Prevention Of Pneumococcal Disease In Infants And Young Children |
| 10th Dec 2009 4:45 pm |
BUS |
Pfizer Announces Updated Trial Results for AROMASIN® (exemestane tablets) In Switch And Upfront Settings |
| 9th Dec 2009 1:00 pm |
BUS |
Physicians More Likely To Report Drug Safety Information Through Electronic Health Records System |
| 9th Dec 2009 7:00 am |
BUS |
Pfizer And Crown Bioscience Announce A Collaboration To Research And Develop New Treatments For Asian Cancers |
| 4th Dec 2009 1:00 pm |
BUS |
Pfizer To Present Clinical Data From Expanded Breast Cancer Portfolio At The San Antonio Breast Cancer Symposium |
| 1st Dec 2009 11:30 am |
BUS |
Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher's Disease Treatment |
| 20th Nov 2009 6:22 pm |
BUS |
Pfizer Receives FDA Approval For Geodon® (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults |
| 20th Nov 2009 1:30 pm |
BUS |
FDA Approves Intravenous Formulation Of Pfizer's Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension |
| 20th Nov 2009 7:00 am |
BUS |
FDA Advisory Committee Finds Data Support the Claim That SPIRIVA® HandiHaler® Reduces COPD Exacerbations |
| 19th Nov 2009 7:00 am |
BUS |
FDA Advisory Committee Finds Data Support the Safety and Effectiveness of Prevnar 13™ Vaccine for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children |
| 18th Nov 2009 1:30 pm |
BUS |
Pfizer and DNDi Advancing International Research Efforts In The Fight Against Neglected Tropical Diseases |
| 18th Nov 2009 9:00 am |
BUS |
Pfizer Submits New Pediatric Data For Lipitor® (Atorvastatin) To The European Medicines Agency (EMEA) |
| 5th Nov 2009 7:00 am |
BUS |
Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX® (Varenicline) Compared With Placebo |
| 3rd Nov 2009 1:00 pm |
BUS |
Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer's Disease |
| 30th Oct 2009 12:30 pm |
BUS |
Pfizer Completes Consent Solicitation |
| 30th Oct 2009 7:00 am |
BUS |
Pfizer's Board Of Directors Approves Shareholder Advisory Vote On Executive Compensation |
| 23rd Oct 2009 7:00 am |
BUS |
Pfizer Declares a 16-Cent Fourth-Quarter 2009 Dividend |
| 20th Oct 2009 12:00 pm |
BUS |
Pfizer Reports Third-Quarter 2009 Results |
| 19th Oct 2009 7:00 am |
BUS |
CP-690,550, Pfizer's Oral JAK Inhibitor, Demonstrates Response Both Alone And In Combination With Methotrexate At 24 Weeks In Patients With Active Rheumatoid Arthritis |
